CAS: 1217516-26-1

Applications An isotopically Labelled metabolite of Itraconazole, an orally active antimycotic structurally related to Ketoconazole. It is a COVID19-related research product. References Saag, M., et al.: Antimicrob. Agents Chemother., 32, 1 (1988), Haria, M., et al.: Drugs, 51, 585 (1996), Kousoulos, C., et al.: Anal. Bioanal. Chem., 384,199 (2006),

Hydroxy itraconazole-d8 is a d8-labeled analog of hydroxy itraconazole. It has been used as a research tool for the study of protein interactions, receptor binding, and ion channel activity. Hydroxy itraconazole-d8 is also used as an inhibitor in cell biology and pharmacology experiments.